|

January 8, 2014

Latham counsels Avalanche Biotechnologies in $142 million financing

Latham & Watkins represented Menlo Park-based Avalanche Biotechnologies Inc. in its $141.6 million follow-on offering of 2,399,457 shares of common stock at $59 per share. Of the total number of shares, 2,009,457 are being offered by Avalanche, while the remaining 390,000 are being offered by existing shareholders.

Menlo Park-based partner Alan Mendelson led the Latham team, with the help of associates Benjamin Potter, W. Riley Lochridge and Alexander White. Partners Judith Hasko and James Metz also provided assistance, along with associate Lilly Fang and San Francisco-based partner Grace M. L. Chen, associate Una Au and counsel Betty Pang. Houston, Texas-based counsel Rebecca Brandt also worked on the deal.